Santhera Pharmaceuticals Holding AG (SWX:SANN)

Switzerland · Delayed Price · Currency is CHF

16.00

-0.34 (-2.08%)

Feb 20, 2026, 5:31 PM CET

Revenue by Segment

Financials in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Development and Commercialization of products for the treatment of Neuromuscular and Pulmonary Diseases	39.12M	103.41M	7.47M	-1.60M	15.01M
Development and Commercialization of products for the treatment of Neuromuscular and Pulmonary Diseases Growth	-62.17%	1283.84%	-	-	-80.09%
Total	39.12M	103.41M	7.47M	-1.60M	15.01M
Total Growth	-62.17%	1283.84%	-	-	-80.09%

Revenue by Geography

Financials in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
North America	11.35M	98.09M	-	-	-
North America Growth	-88.43%	-	-	-	-
Europe	14.97M	3.40M	-3.72M	-1.60M	15.00M
Europe Growth	340.04%	-	-	-	-80.05%
Asia	12.79M	1.92M	11.19M	-	-
Asia Growth	565.96%	-82.83%	-	-	-
Rest of The World	-	-	-	-	7.00K
Rest of The World Growth	-	-	-	-	-96.43%
Total	39.12M	103.41M	7.47M	-1.60M	15.01M
Total Growth	-62.17%	1283.84%	-	-	-80.09%

Source: S&P Global Market Intelligence.